The seroprevalence of TTIs in blood donors showed an increasing trend for HIV, HCV, and HBsAg in 2019–2021, whereas there was a decrease in reactivity status in the 2022 (back to pre-pandemic year).
← all excerpts
Trends of coinfections among healthy blood donors: COVID-19 pandemic repercussion.
1
—
—